Fig. 6From: Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNATumor growth inhibition effects of SCNTs/si-circPRMT5 in the subcutaneous model. (A) T24 tumor treatment schedule. (B) Growth curves of tumors of mice treated with different therapeutic regimens (n = 5). (C) The excised tumor tissue weight from all the groups. Data represent the mean ± SD (n = 5). (D) Body weight changes during treatment. Data represent the mean ± SD (n = 5). (E) Mouse tumor morphology. (F) Survival rate of BALB/c nude mice bearing T24 tumors. ***P < 0.001Back to article page